Nausea-reducing multivitamin composition
A clinically proven ingredient integrated into multivitamins to reduce nausea, enhancing user comfort and compliance.
Overview
This innovative multivitamin composition includes a clinically proven ingredient specifically designed to reduce nausea, a common side effect associated with multivitamin intake. The integration of this ingredient aims to enhance user comfort and improve compliance with daily vitamin regimens.
Technical specifications
The key feature of this solution is the inclusion of a nausea-reducing ingredient that is already clinically validated. This ingredient works by counteracting the common triggers of nausea associated with multivitamin consumption, ensuring a more pleasant experience for users. The formulation retains the essential nutrients provided by standard multivitamins while adding this unique benefit.
Technology readiness level
This composition has reached Technology Readiness Level 9, indicating it is ready for full-scale deployment and commercialization.
About Olene Life Science Pvt.Ltd
Olene Life Sciences Pvt. Ltd. is a Chennai-based nutraceutical and agrifoods company established in 2015 that focuses on the research, development, and manufacturing of clinically validated, nature-inspired health solutions. The company differentiates itself through disruptive innovation, utilizing its proprietary, patented technology platforms such as Aqueosome and Self-D to enhance the bioavailability, concentration, and sustained release of phytochemicals. By avoiding generic formulations, Olene centers its operations on creating intellectually protected, original ingredients that bridge the gap between nature and science. Their portfolio includes various evidence-based solutions for digestive health, pain management, cardiovascular support, and cognitive enhancement, all backed by clinical studies.
Olene serves the global nutraceutical market by providing industry partners with high-quality, standardized, and effective ingredients that address specific wellness needs. The company’s commitment to evidence-based development is evidenced by its extensive intellectual property portfolio, which includes over 110 global IP applications, and its focus on rigorous clinical validation for its products. By offering these scientifically advanced ingredients, Olene helps nutraceutical brands improve their product pipelines and provide consumers with safe, effective alternatives for managing health conditions ranging from menstrual discomfort to metabolic and cognitive health issues. The company maintains a global reach, with products recognized across markets in the USA, EU, Australia, and India.
delivered to your inbox.